Novel sites for phenylalkylamines: characterisation of a sodium-sensitive drug receptor with (−)-[3H]emopamil
- 14 October 1991
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 208 (2) , 119-130
- https://doi.org/10.1016/0922-4106(91)90062-m
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- (S)-emopamil protects against global ischemic brain injury in rats.Stroke, 1990
- Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamilInternational Journal of Cancer, 1990
- S-emopamil ameliorates ischemic brain damage in rats: Histological and behavioural approachesLife Sciences, 1990
- The Ca2+ channel and 5-HT2 receptor antagonist (s)-emopamil in cerebral ischaemiaTrends in Pharmacological Sciences, 1989
- (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of α1-adrenoceptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolitesLife Sciences, 1989
- Amiloride and its analogs as tools in the study of ion transportThe Journal of Membrane Biology, 1988
- Effects of Calcium Entry Blocker Emopamil on Postischemic Energy Metabolism of the Isolated Perfused Rat BrainJournal of Cerebral Blood Flow & Metabolism, 1987
- Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse‐tubule calcium channelFEBS Letters, 1987
- Interaction of guanidinium and guanidinium derivatives with the Na+/H+ exchange systemEuropean Journal of Biochemistry, 1985